The PARP & DDR Inhibitors Summit Digital is dedicated to cancer survival mechanisms with next generation PARP & DNA damage response (DDR) inhibitors.
The PARP & DDR Inhibitors Summit Digital covers topics such as:
- Examining genotypes and biomarker strategy for personalized treatment plans
- Drug and therapeutic combinations and lessons learnt from PARP in the clinic
- Therapeutic combination selection to overcome acquired resistance
- DDR inhibitors for use in expanded indications
- The emerging DDR therapeutic landscape and unpick the complex DDR network
